DNA hypermethylation and clinicopathological features in breast cancer: The Western New York Exposures and Breast Cancer (WEB) Study

Breast Cancer Research and Treatment

Volumn 114, Issue 3, 2009, Pages 559-568

  Tao, Meng Hua ^a   Shields, Peter G ^b   Nie, Jing ^a   Millen, Amy ^a   Ambrosone, Christine B ^c   Edge, Stephen B ^c   Krishnan, Shiva S ^b   Marian, Catalin ^b   Xie, Bin ^b   Winston, Janet ^d   Vito, Dominica ^a   Trevisan, Maurizio ^a   Freudenheim, Jo L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d Potomac Hospital   (United States)

Author keywords

Breast cancer; Epidemiology; Estrogen receptor; Hypermethylation; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; DNA ISOLATION; DNA METHYLATION; E CADHERIN GENE; FEMALE; GENE; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; P16 GENE; POSTMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; RAR BETA2 GENE; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CASE-CONTROL STUDIES; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEW YORK; POSTMENOPAUSE; RECEPTORS, PROGESTERONE; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 61449148691     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0028-z     Document Type: Article

References (38)

1. SA Wajed PW Laird TR DeMeester 2001 DNA methylation: an alternative pathway to cancer Ann Surg 234 10 20
2. SB Baylin JG Herman 2000 DNA hypermethylation in tumorigenesis: epigenetics joins genetics Trends Genet 16 168 174
3. M Esteller PG Corn SB Baylin JG Herman 2001 A gene hypermethylation profile of human cancer Cancer Res 61 3225 3229
4. M Esteller JM Silva G Dominguez 2000 Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors J Natl Cancer Inst 92 564 569
5. JR Graff JG Herman RG Lapidus 1995 E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas Cancer Res 55 5195 5199
6. M Widschwendter AJ Peter 2002 DNA methylation and breast carcinogenesis Oncogene 21 5462 5482
7. V Raman SA Martensen D Reisman 2000 Compromised HOXA5 function can limit p53 expression in human breast tumors Nature 405 974 978
8. A Wiley D Katasaros H Chen 2006 Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential Cancer 107 299 308
9. M Toyota N Ahuja H Suzuki 1999 Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype Cancer Res 59 5438 5442
10. K Bannon M Yanokura N Susumu 2006 Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer Oncol Rep 16 1189 1196
11. DH Jeong MY Youm YN Kim 2006 Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics Int J Gynecol Cancer 16 1234 1240
12. SA Belinsky KC Liechty FD Gentry 2006 Promoter hypermthylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort Cancer Res 66 3338 3344
13. YK Bae A Brown E Garrett 2004 Hypermethylation in histologically distinct classes of breast cancer Clin Cancer Res 10 5988 6005
14. SY Li M Rong B Iacopetta 2006 DNA hypermethylation in breast cancer and its association with clinicopathological features Cancer Lett 237 272 280
15. M Shinozaki DSB Hoon AE Giuliano 2005 Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis Clin Cancer Res 11 2156 2162
16. P Parrella ML Poeta AP Gallo 2004 Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors Clin Cancer Res 10 5349 5354
17. JM Garcia J Silva C Pena 2004 Promoter methylation of the PTEN gene is a common molecular change in breast cancer Genes Chromosomes Cancer 41 117 124
18. J Mehrotra M Vali M McVeigh 2004 Very high frequency of hypermthylated genes in breast cancer metastasis to the bone, brain, and lung Clin Cancer Res 10 3104 3109
19. PS Yan MR Perry DE Laux AL Asare CW Caldwell TH Huang 2006 CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer Clin Cancer Res 6 1432 1438
20. DC Allred JM Harvey M Berardo GM Clark 1998 Prognostic and predictive factors in breast cancer by immumohistochemical analysis Mod Pathol 11 155 168
21. M Tennis S Krishnan M Bonner 2006 p53 Mutation analysis in breast tumors by a DNA microarray method Cancer Epidemiol Biomarkers Prev 15 80 85
22. C Jeronimo H Usadel R Henrique 2001 Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma J Natl Cancer Inst 93 1447 1452
23. SV Harden Y Tokumaru WH Westra 2003 Gene promoter hypermethylation in tumors and lymph nodes of stage 1 lung cancer patients Clin Cancer Res 9 1370 1375
24. H Usadel J Brabender KD Danenberg 2002 Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 371 375
25. JR Graff E Gabrelson H Fujii SB Baylin JG Herman 2000 Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic heterogeneous loss of E-cadherin expression during metastatic progression J Biol Chem 275 2727 2732
26. NM Hazan R Qiao R Keren I Badano K Suyama 2004 Cadherin switch in tumor progression Ann N Y Acad Sci 1014 155 163
27. KM Rieger-Christ JA Pezza JM Dugan 2001 Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas Mol Pathol 54 91 97
28. H More B Humar W Weber 2007 Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene Hum Mutat 28 203
29. JI Risinger A Berchuck MF Kohler J Boyd 1994 Mutations of the E-cadherin gene in human gynecologic cancers Nat Genet 7 98 102
30. SJ Nass JG Herman E Gabrielson 2000 Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer Cancer Res 60 4346 4348
31. S Droufakou V Deshmane R Roylance A Hanby I Tomlinson IR Hart 2001 Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast Int J Cancer 92 404 408
32. JR Caldeira EC Prando FC Quevedo FA Neto CA Rainho SR Rogatto 2006 CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer BMC Cancer 6 48
33. P Lipponen E Saarelainen H Ji S Aaltomaa K Syrjanen 1994 Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer J Pathol 174 101 109
34. C Charpin S Garcia C Bouvier 1997 E-cadherin quantitative immunocytochemical assays in breast carcinomas J Pathol 181 294 300
35. CJ Sherr 1996 Cancer cell cycles Science 274 1672 1677
36. TD Tlsty YG Crawford CR Holst 2004 Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis J Mammary Gland Biol Neoplasia 9 263 274
37. CR Holst GJ Nuovo M Esteller 2003 Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia Cancer Res 63 1596 1601
38. CM Lewis LR Cler DW Bu 2005 Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk Clin Cancer Res 11 166 172